143 related articles for article (PubMed ID: 6515125)
1. Inhibitors of phenylethanolamine-N-methyltransferase: effects on brain catecholamine content and blood pressure in DOCA-salt hypertensive rats.
Liang NY; Chandra A; Tessel RE; Grunewald GL; Borchardt RT
Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):319-29. PubMed ID: 6515125
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of phenylethanolamine-N-methyltransferase. 2. Comparison of nonaromatic analogs of phenylethanolamines, 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (SKF-64139) and 2,3-dichloro-alpha-methylbenzylamine: effects on rat brain and adrenal catecholamine content and blood pressure.
Liang NY; Tessel RE; Grunewald GL; Borchardt RT
J Pharmacol Exp Ther; 1982 Nov; 223(2):382-7. PubMed ID: 7131293
[TBL] [Abstract][Full Text] [Related]
3. Effects of phenylethanolamine N-methyltransferase inhibitors on uptake and release of norepinephrine and dopamine from rat brain.
Liang NY; Hower JA; Borchardt RT
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):467-70. PubMed ID: 4059661
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of phenylethanolamine N-methyltransferase. 1. Effects of 2-cycloocytyl-2-hydroxyethylamine on rat brain and adrenal catecholamine content and blood pressure.
Liang NY; Tessel RE; Grunewald GL; Borchardt RT
J Pharmacol Exp Ther; 1982 Nov; 223(2):375-81. PubMed ID: 7131292
[TBL] [Abstract][Full Text] [Related]
5. Effects of brain epinephrine depletion on thermoregulation, reflex bradycardia, and motor activity in rats.
Tsai SH; Shih CJ; Lin MT
Exp Neurol; 1985 Mar; 87(3):428-38. PubMed ID: 3972046
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of CGS 19281A, an inhibitor of phenylethanolamine-N-methyltransferase.
Chatelain RE; Manniello MJ; Dardik BN; Rizzo M; Brosnihan KB
J Pharmacol Exp Ther; 1990 Jan; 252(1):117-25. PubMed ID: 2153796
[TBL] [Abstract][Full Text] [Related]
7. Effects of phenylethanolamine N-methyltransferase inhibitors on rat brain catecholamine levels and body temperature.
Liang NY; Borchardt RT; Choi JC; Tessel RE; Grunewald GL
Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):445-52. PubMed ID: 7178654
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats.
Hahn RA; Fuller RW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1983 Jul; 226(1):39-45. PubMed ID: 6864549
[No Abstract] [Full Text] [Related]
9. Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism.
Stolk JM; Vantini G; Perry BD; Guchhait RB; U'Prichard DC
J Pharmacol Exp Ther; 1984 Sep; 230(3):577-86. PubMed ID: 6147403
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular activity of SK&F 64139 in the hypertensive rat.
Hieble JP; McCafferty JP; Roesler JM; Pendleton RG; Gessner G; Carey R; Sarau HM; Goldstein M
J Cardiovasc Pharmacol; 1983; 5(5):889-97. PubMed ID: 6195482
[TBL] [Abstract][Full Text] [Related]
11. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
[TBL] [Abstract][Full Text] [Related]
12. Acute cardiovascular effects of two central phenylethanolamine-N-methyl-transferase inhibitors in unanesthetized desoxycorticosterone-salt hypertensive rats.
Biollaz B; Biollaz J; Kohlman O; Bresnahan M; Gavras I; Gavras H
Eur J Pharmacol; 1984 Jul; 102(3-4):515-9. PubMed ID: 6489438
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
[TBL] [Abstract][Full Text] [Related]
15. Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats.
Elhaïmeur F; Courderot-Masuyer C; Nicod L; Bobillier-Chaumont S; Robin S; Richert L; Berthelot A
Can J Physiol Pharmacol; 2003 May; 81(5):469-75. PubMed ID: 12774853
[TBL] [Abstract][Full Text] [Related]
16. [Asymmetrical content of dopamine-beta-hydroxylase and phenylethanolamine-N-methyltransferase in the adrenals of spontaneously hypertensive and normotensive Wistar-Kyoto rats].
Hilse H; Oehme P; Hecht K
Biomed Biochim Acta; 1983; 42(6):745-50. PubMed ID: 6639646
[TBL] [Abstract][Full Text] [Related]
17. Adrenaline neurons and PNMT activity in the brain and spinal cord of genetically hypertensive rats and rats with DOCA--salt hypertension.
Chalmers JP; Howe PR; Wallmann Y; Tumuls I
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():219s-221s. PubMed ID: 7318327
[TBL] [Abstract][Full Text] [Related]
18. Epinephrine regulation of hemodynamics in catecholamine knockouts and the pithed mouse.
Sun P; Bao X; Elayan H; Milic M; Liu F; Ziegler MG
Ann N Y Acad Sci; 2008 Dec; 1148():325-30. PubMed ID: 19120125
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of adrenaline-forming enzyme in the brain prevents one-kidney, one-clip hypertension and deoxycorticosterone acetate-salt hypertension in the rabbit.
Rosendorff C; Melamed JR; Hurwitz ML; Coull A; Jarvis A
Clin Sci (Lond); 1982 Dec; 63(6):573-6. PubMed ID: 7128025
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure response to central and/or peripheral inhibition of phenylethanolamine N-methyltransferase in normotensive and hypertensive rats.
Black J; Waeber B; Bresnahan MR; Gavras I; Gavras H
Circ Res; 1981 Aug; 49(2):518-24. PubMed ID: 7249286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
